A C W Zannettino

Author PubWeight™ 8.84^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	The emerging role of hypoxia, HIF-1 and HIF-2 in multiple myeloma.	Leukemia	2011	1.39
2	Enrichment for STRO-1 expression enhances the cardiovascular paracrine activity of human bone marrow-derived mesenchymal cell populations.	J Cell Physiol	2010	1.26
3	Human osteoblasts are resistant to Apo2L/TRAIL-mediated apoptosis.	Bone	2002	1.01
4	Tug of war in the haematopoietic stem cell niche: do myeloma plasma cells compete for the HSC niche?	Blood Cancer J	2012	0.96
5	Chronic myeloid leukemia CD34+ cells have reduced uptake of imatinib due to low OCT-1 activity.	Leukemia	2010	0.94
6	Imatinib mesylate causes growth plate closure in vivo.	Leukemia	2009	0.92
7	Therapeutic concentrations of dasatinib inhibit in vitro osteoclastogenesis.	Leukemia	2008	0.92
8	The tyrosine kinase inhibitor dasatinib (SPRYCEL) inhibits chondrocyte activity and proliferation.	Blood Cancer J	2011	0.79
9	Cardiac magnetic resonance, transthoracic and transoesophageal echocardiography: a comparison of in vivo assessment of ventricular function in rats.	Lab Anim	2013	0.75